[1] |
Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022:GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2024,74(3):229-263.
|
[2] |
Racz JM, Caudle AS. Sentinelnode lymph node surgery after neoadjuvant therapy: principles and techniques[J]. Ann Surg Oncol,2019, 26(10): 3040-3045.
|
[3] |
中国抗癌协会乳腺癌专业委员会, 中华医学会肿瘤学分会乳腺肿瘤学组. 中国抗癌协会乳腺癌诊治指南与规范(2024 年版)[J]. 中国癌症杂志, 2023, 33(12): 1092-1187.
|
[4] |
Martin EA, Chauhan N, Dhevan V, et al. Current status of biopsy markers for the breast in clinical settings[J].Expert Rev Med Devic,2022, 19(12): 965-975.
|
[5] |
中华医学会外科学分会乳腺外科学组, 陈武臻, 黄建, 等. 中国可视化经皮穿刺乳腺组织定位导丝与定位标记夹临床实践指南(2022 版)[J]. 中国实用外科杂志, 2022, 42(8):850-857.
|
[6] |
Kaplan JA,Grinstaff MW,Bloch BN.Polymer film-nanoparticle composites as new multimodality, non-migrating breast biopsy markers [ J].Eur Radiol, 2016, 26(3): 866-873.
|
[7] |
Genson CC, Blane CE, Helvie MA, et al. Effects on breast MRI of artifacts caused by metallic tissue marker clips[J].Am J Roentgenol,2007, 188(2): 372-376.
|
[8] |
Tan MP, Bi Z, Ong EMW. The ‘twinkle’ artifact - A novel method of clip identification to facilitate targeted axillary surgery following neoadjuvant chemotherapy in breast cancer patients[J].Clin Imag,2020, 68: 36-44.
|
[9] |
Shah AD, Mehta AK, Talati N, et al. Breast tissue markers:why?what’s out there?how do I choose? [J]. Clin Imag,2018,52:123-136.
|
[10] |
Wood MM, Warshaw EM. Hypersensitivityreactions to titanium:diagnosis and management[J]. Dermatitis, 2015, 26(1): 7-25.
|
[11] |
Portnow LH, Kwak E, Senapati GM, et al. Ultrasound visibility of select breast biopsy markers for targeted axillary node localization following neoadjuvant treatment: simulation using animal tissue models[J].Breast Cancer Res Tr, 2020, 184(1): 185-192.
|
[12] |
Szold A. Nitinol:shape-memory and super-elastic materials in surgery[J].Surg Endosc, 2006, 20(9): 1493-1496.
|
[13] |
Sakamoto N, Ogawa Y, Tsunoda Y, Fukuma E. Evaluation of the sonographic visibility and sonographic appearance of the breast biopsy marker (UltraClip©) placed in phantoms and patients[J]. Breast Cancer, 2017, 24(4):585-592.
|
[14] |
Clarke R, Suresh P, Thomas R, et al. Twinkle artefact in the ultrasound diagnosis of superficial epidermoid cysts[J]. Ultrasound,2016, 24(3): 147-153.
|
[15] |
Arjmandi F, Mootz A, Farr D, et al. New horizons in imaging and surgical assessment of breast cancer lymph node metastasis[J]. Breast Cancer Res Treat, 2021, 187(2): 311-322.
|
[16] |
Ghate SV, Baker JA, Hawkins AD, et al. Titanium vs carbon coated ceramic breast tissue marker clips: 3T MR susceptibility artifact and local signal disturbance[J]. Acad Radiol, 2011, 18(6): 770-773.
|
[17] |
Seow JH, Phillips M, Taylor D. Sonographic visibility of breast tissue markers: A tissue phantom comparison study[J]. Australas J Ultrasound Med, 2012, 15(4): 149-157.
|
[18] |
Han KH, Lee JY, Shin SW. Implant- and Tooth-supported fixed prostheses using a high-performance polymer (pekkton) pramework[J].Int J Prosthodont, 2016, 29(5): 451-454.
|
[19] |
Yen P, Dumas S, Albert A, et al. Post-vacuum-assisted stereotactic core biopsy clip displacement: a comparison between commercially available clips and surgical clip[J]. Can Assoc Radiol J,2018,69(1):10-15.
|
[20] |
Eby PR, Calhoun KE, Kurland BF, et al. Preoperative and intraoperative sonographic visibility of collagen-based breast biopsy marker clips[J]. Acad Radiol, 2010, 17(3): 340-347.
|
[21] |
Pinkney DM, Mychajlowycz M, Shah BA. A prospective comparative study to evaluate the displacement of four commercially available breast biopsy markers[J]. Brit J Radiol, 2016, 89(1065):20160149.
|
[22] |
Pinkney DM, Shah BA. Prospective comparative study to evaluate the sonographic visibility of five commercially available breast biopsy markers[J]. J Diagn Med Sonogr, 2013, 29(4): 151-158.
|
[23] |
Mcmahon MA, James JJ, Cornford EJ, et al. Does the insertion of a gel-based marker at stereotactic breast biopsy allow subsequent wire localizations to be carried out under ultrasound guidance? [J]. Clin Radiol, 2011, 66(9): 840-844.
|
[24] |
Alshafeiy TI, Matich A, Rochman CM, et al. Advantages and challenges of using breast biopsy markers[J]. J Breast Imaging, 2022,4(1): 78-95.
|
[25] |
Seyednejad H,Imani N,Jamieson T,et al. Topical haemostatic agents[J].Br J Surg, 2008, 95(10): 1197-1225.
|
[26] |
Barentsz MW, Van Den Bosch MA, Veldhuis WB, et al. Radioactive seed localization for non-palpable breast cancer[J]. Br J Surg, 2013,100(5): 582-588.
|
[27] |
Miller ME, Patil N, Li P, et al. Hospital system adoption of magnetic seeds for wireless breast and lymph node localization[J]. Ann Surg Oncol, 2021, 28(6): 3223-3229.
|
[28] |
Lamb LR, Bahl M, Lehman CD. Evaluation of a nonradioactive magnetic marker wireless localization program[J]. Am J Roentgenol,2018, 211(4): W202.
|
[29] |
Haim Zada M, Gallimidi Z,Schlesinger Laufer M,et al. Biodegradable breast tissue marker clip[J]. ACS Appl Bio Mater, 2020, 3(11):7439-7453.
|
[30] |
Nurko J, Mancino AT, Whitacre E, et al. Surgical benefits conveyed by biopsy site marking system using ultrasound localization[J]. Am J Surg, 2005, 190(4): 618-622.
|
[31] |
Thomassin-Naggara I, Lalonde L, David J, et al. A plea for the biopsy marker: how, why and why not clipping after breast biopsy? [J].Breast Cancer Res Treat, 2012, 132(3): 881-893.
|
[32] |
Meissnitzer M, Dershaw DD,Lee CH,et al. Targeted ultrasound of the breast in women with abnormal MRI findings for whom biopsy has been recommended[J]. Am J Roentgenol, 2009, 193(4): 1025-1029.
|
[33] |
Burbank F, Forcier N. Tissue marking clip for stereotactic breast biopsy: initial placement accuracy,long-term stability,and usefulness as a guide for wire localization[J]. Radiology,1997,205(2):407-415.
|
[34] |
Edeiken BS, Fornage BD, Bedi DG, et al. US-guided implantation of metallic markers for permanent localization of the tumor bed in patients with breast cancer who undergo preoperative chemotherapy [ J].Radiology, 1999, 213(3): 895-900.
|
[35] |
Cangiarella J, Gross J, Symmans WF, et al. The incidence of positive margins with breast conserving therapy following mammotome biopsy for microcalcification[J]. J Surg Oncol, 2000, 74(4): 263-266.
|
[36] |
Cortazar P, Zhang L, Untch M, et al. Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis[J]. Lancet, 2014, 384(9938): 164-172.
|
[37] |
Woriax HE, Thomas SM, Plichta JK, et al. Racial/Ethnic disparities in pathologic complete response and overall survival in patients with triple-negative breast cancer treated with neoadjuvant chemotherapy[J].J Clin Oncol, 2024,42(14):1635-1645.
|
[38] |
Esserman LE, Cura MA, Dacosta D. Recognizing pitfalls in early and late migration of clip markers after imaging-guided directional vacuumassisted biopsy[J]. Radiographics, 2004, 24(1): 147-156.
|
[39] |
陈武臻, 陈志烨, 于秀艳, 等. 可视化经皮穿刺乳腺病灶定位标记夹的临床应用[J]. 中国实用外科杂志, 2018, 38(11):1248-1254.
|
[40] |
Jain A, Khalid M, Qureshi MM, et al. Stereotactic core needle breast biopsy marker migration:An analysis of factors contributing to immediate marker migration[J]. Eur Radiol,2017,27(11):4797-4803.
|
[41] |
Di Paola V, Mazzotta G, Conti M, et al. Image-guided localization techniques for metastatic axillary lymph nodes in breast cancer; what radiologists should know[J]. Cancers, 2023, 15(7):2130.
|
[42] |
Calhoun K, Giuliano A, Brenner RJ. Intraoperative loss of core biopsy clips: clinical implications[J]. Am J Roentgenol, 2008, 190(3):W196-W200.
|
[43] |
Klein RL, Mook JA, Euhus DM, et al. Evaluation of a hydrogel based breast biopsy marker (HydroMARK) as an alternative to wire and radioactive seed localization for non-palpable breast lesions[J]. J Surg Oncol, 2012, 105(6): 591-594.
|
[44] |
Motton S,Gardinal I, Soulé-Tholy M, et al. [Hurt eczematiforme column(chronicle) of the breast after implementation of a surgical clip][J].J Gynecol Obstet Biol Reprod (Paris),2011,40(2):174-177.
|